A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.

@article{Arcinue2013ACB,
  title={A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.},
  author={Cheryl A. Arcinue and Olga M Cer{\'o}n and Charles Stephen Foster},
  journal={Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics},
  year={2013},
  volume={29 5},
  pages={501-7}
}
PURPOSE To evaluate the efficacy and safety of the fluocinolone acetonide (Retisert) implant compared with the dexamethasone (Ozurdex) implant in patients with noninfectious uveitis. DESIGN Comparative case series. STUDY PARTICIPANTS Twenty-seven eyes received either the fluocinolone acetonide (FA) (n=16) or dexamethasone (n=11) implant. METHODS Chart review of patients at the Massachusetts Eye Research and Surgery Institution (MERSI) was done and patients were selected and matched… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS
25 Citations
13 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 25 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 13 references

amethasone intravitreal implant for noninfectious intermediate or posterior uveitis

  • C. Lowder, S. Lightman
  • Arch . Ophthalmol .
  • 2011

Similar Papers

Loading similar papers…